Download - Pitutary tumors and management
![Page 1: Pitutary tumors and management](https://reader035.vdocuments.mx/reader035/viewer/2022062823/5873c73e1a28abbc788b7da5/html5/thumbnails/1.jpg)
Pituitary Tumors
Dr. Romi Grover
![Page 2: Pitutary tumors and management](https://reader035.vdocuments.mx/reader035/viewer/2022062823/5873c73e1a28abbc788b7da5/html5/thumbnails/2.jpg)
Anatomy
• Hypophysis cerebri.• Ovoid body situated in the hypophysial fossa
of the sphenoid bone known as sella turcica.• Weight : 0.8 gm.• Size : 1.3x1x0.5 cm.
![Page 3: Pitutary tumors and management](https://reader035.vdocuments.mx/reader035/viewer/2022062823/5873c73e1a28abbc788b7da5/html5/thumbnails/3.jpg)
Embryology
• Entirely ectodermal in origin– Adenohypophysis
• Develops from Rathke’s pouch
• Upward invagination– Neurohypophysis
• Develops from the infundibulum
• Downward extension of the floor of the diencephalon
![Page 4: Pitutary tumors and management](https://reader035.vdocuments.mx/reader035/viewer/2022062823/5873c73e1a28abbc788b7da5/html5/thumbnails/4.jpg)
Parts
On embryological basis: Adenohypophysis (80%)• Pars infundibularis• Pars intermedia• Pars distalisNeurohypophysis (20%)• Median eminence• Infundibular stem• Infundibular process
![Page 5: Pitutary tumors and management](https://reader035.vdocuments.mx/reader035/viewer/2022062823/5873c73e1a28abbc788b7da5/html5/thumbnails/5.jpg)
• Adenohypophysis : superior Hypophysial artery: hypophyseal portal system
• Neurohypophysis : inferior hypophyseal artery.
• Hence, Dual circulation.o Arteries & veins o Portal venous system
![Page 6: Pitutary tumors and management](https://reader035.vdocuments.mx/reader035/viewer/2022062823/5873c73e1a28abbc788b7da5/html5/thumbnails/6.jpg)
Relations
![Page 7: Pitutary tumors and management](https://reader035.vdocuments.mx/reader035/viewer/2022062823/5873c73e1a28abbc788b7da5/html5/thumbnails/7.jpg)
Physiology Anterior lobe • Somatotrophs [50%]: acidophilic, GH.• Lactotrophs : acidophilic, Prolactin.• Corticotrophs : Basophilic, ACTH, pro-
opiomelanocortin, MSH, endorphins & lipotropin.• Thyrotrophs : TSH.• Gonadotrophs : Basophilic, FSH-LH. Posterior lobe • Oxytocin.• ADH.
![Page 8: Pitutary tumors and management](https://reader035.vdocuments.mx/reader035/viewer/2022062823/5873c73e1a28abbc788b7da5/html5/thumbnails/8.jpg)
Epidemiology • Pituitary tumors are relatively uncommon • Comprising 10-12% of all intracranial tumors.
• Up to 22% of normal pituitary gland show adenoma at the time of autopsy • Most tumour present with in 30- 50 yrs
• 3-7 % under the age of 20 years
![Page 9: Pitutary tumors and management](https://reader035.vdocuments.mx/reader035/viewer/2022062823/5873c73e1a28abbc788b7da5/html5/thumbnails/9.jpg)
Etiology • Unknown • Genetic factors
MEN-1 syndrome Autosomal dominant syndrome
characterize by the development of tumour of pituitary, parathyroid, pancreatic islets cell
Three% of all tumour arise as a results of MEN 1 PA develops in 25 %patients with MEN-1
![Page 10: Pitutary tumors and management](https://reader035.vdocuments.mx/reader035/viewer/2022062823/5873c73e1a28abbc788b7da5/html5/thumbnails/10.jpg)
Classification • Pituitary tumors can be classified into three groups
according to their biological behavior:– Benign, – Invasive adenoma, and– Carcinoma.
• Invasive adenomas- may invade into the dura mater, cranial bone, or sphenoid sinus.
• Carcinomas account for 0.1% or 0.2% of all pituitary tumors
![Page 11: Pitutary tumors and management](https://reader035.vdocuments.mx/reader035/viewer/2022062823/5873c73e1a28abbc788b7da5/html5/thumbnails/11.jpg)
• Based on radiological findings. – Microadenomas (i.e., the greatest diameter is <10 mm) corticotrophs, lactotrophs. – Macroadenomas (i.e., the greatest diameter is ≥I0 mm). functioning & Non- functioning.
• Most pituitary adenomas are microadenomas.
• Functional criteria- which are used to define tumors in terms of their endocrine activity in vivo.– Functional [ acidophilic /basophilic]– Nonfunctional : [chromophobic]
![Page 12: Pitutary tumors and management](https://reader035.vdocuments.mx/reader035/viewer/2022062823/5873c73e1a28abbc788b7da5/html5/thumbnails/12.jpg)
Clinical presentationHormone Signs and
symptoms of hypersecretion
Signs and symptoms of hyposecretion
Lab Values
FSH, LH Clinically silent Mood swings, impotence, vaginal dryness, hot flashes, osteoporosis, decreased libido
LH, FSH, Serum testosterone, Serum estradiol
ACTH Cushing’s disease-moon facies, buffalo hump, puple striae, hypertension
Weight loss, nausia, hyponatremia and hypoglycemia, hypotension, fatigue
Serum cortisol
TSH Goiter, moist skin, tachycardia, palpitations, insomnia
Weight gain, fatigue, constipation, cold intolerance, bradycardia
TSH, free T4
![Page 13: Pitutary tumors and management](https://reader035.vdocuments.mx/reader035/viewer/2022062823/5873c73e1a28abbc788b7da5/html5/thumbnails/13.jpg)
Hormone Signs and symptoms of hypersecretion
Signs and symptoms of hyposecretion
Lab Values
Prolactin Menstrual irregularites, infertility, galactorrhea, weight gain
Silent Prolactin
GH Acromegaly-overgrowth, carpal tunnel, hyperhidrosis
Dwarfism, fatigue, osteoporosis, weight gain
IGF-1, GH
![Page 14: Pitutary tumors and management](https://reader035.vdocuments.mx/reader035/viewer/2022062823/5873c73e1a28abbc788b7da5/html5/thumbnails/14.jpg)
• Posterior gland (Neurohypophysis)– Oxytocin• Uterine contractions and lactation
– Anti-diuretic hormone• SIADH-increased water resorption, low sodium• DI-increased urination, high sodium
![Page 15: Pitutary tumors and management](https://reader035.vdocuments.mx/reader035/viewer/2022062823/5873c73e1a28abbc788b7da5/html5/thumbnails/15.jpg)
Disorders associated with the adjacent compression
• Lateral: Cavernous sinuses : diplopia, opthalmoplegia, ptosis, diminished corneal sensation, or facial paresthesias in the upper face.
• Superior: optic chiasm & hypothalamus.• Inferior: sphenoid sinus.
![Page 16: Pitutary tumors and management](https://reader035.vdocuments.mx/reader035/viewer/2022062823/5873c73e1a28abbc788b7da5/html5/thumbnails/16.jpg)
• Pitutary Apoplexy : • severe headache• altered consciousness• opthalmoplegia• blindness.• severe hypopituitarism • Medical emergency : administration of stress
doses of steroids, fluid , and pain control. Urgent surgery is also generally warranted to avoid potential permanent sequelae.
![Page 17: Pitutary tumors and management](https://reader035.vdocuments.mx/reader035/viewer/2022062823/5873c73e1a28abbc788b7da5/html5/thumbnails/17.jpg)
Types of Adenomas
• Prolactinomas : 40% to 45% of all pituitary tumors.
• Women > men.• Clinical presentation: Oligo/amenorrhea, galactorrhea, infertility &
androgenization with hirsutism & acne in women.
Reduced sexual function and libido in men.
![Page 18: Pitutary tumors and management](https://reader035.vdocuments.mx/reader035/viewer/2022062823/5873c73e1a28abbc788b7da5/html5/thumbnails/18.jpg)
• Acromegaly : GH hypersecretion • Source somatotroph adenoma Ectopic GH/GHRH.• Insidious nature – delayed diagnosis- macro adenomas
at detection.• Growth of hands and feet. • Jaw growth and prognathism • Hypertrophic cardiomyopathy.• Sleep apnea syndrome• Arthropathy, colon polyps• Carpal tunnel syndrome• Headache.
![Page 19: Pitutary tumors and management](https://reader035.vdocuments.mx/reader035/viewer/2022062823/5873c73e1a28abbc788b7da5/html5/thumbnails/19.jpg)
• Cushing's Disease : overproduction of glucocorticoids .• Obesity• Diabetes mellitus• Hypertension• Muscle wasting• Osteoporosis• Depression• Coagulopathy• cognitive deficits.• the 5-year cardiovascular mortality for untreated
disease is 50%
![Page 20: Pitutary tumors and management](https://reader035.vdocuments.mx/reader035/viewer/2022062823/5873c73e1a28abbc788b7da5/html5/thumbnails/20.jpg)
• Nonfunctioning Pituitary Adenomas : • Detected incidentally• Workup of visual field loss, headache, modest
hyperprolactinemia (from compression of the hypophyseal stalk), or hypopituitarism.
![Page 21: Pitutary tumors and management](https://reader035.vdocuments.mx/reader035/viewer/2022062823/5873c73e1a28abbc788b7da5/html5/thumbnails/21.jpg)
Evaluation • History and physical examination with detailed
neurological examination.• Comprehensive endocrine evaluation. S. Prolactin [ > 200ng/ml] Basal GH, IGF-1, glucose suppression, insulin
tolerence, TRH stimulation S.ACTH, 24 Hr Urine for 17 OH corticosteroids,
dexamethasone supression test.ACTH from B/L inf. Petrosal sinuses.TSH,T3, T4.FSH, LH, testosterone levels, estradiol levels.
![Page 22: Pitutary tumors and management](https://reader035.vdocuments.mx/reader035/viewer/2022062823/5873c73e1a28abbc788b7da5/html5/thumbnails/22.jpg)
• CEMRI brain.• Neuro-opthalmologic examination with visual
field tests.• Skeletal survey : acromegaly.
![Page 23: Pitutary tumors and management](https://reader035.vdocuments.mx/reader035/viewer/2022062823/5873c73e1a28abbc788b7da5/html5/thumbnails/23.jpg)
Hardy & Vezina Staging System• Gr I: normal sized sella with possible
asymmetry of the floor. • Gr II: Enlarged sella with an intact floor.• Gr III: Localized erosion or destruction of the
sellar floor.• Gr IV: Diffusely eroded or destroyed floor. Gr-I & G II – enclosed adenomas. Gr-III & Gr IV – invasive adenomas.
![Page 24: Pitutary tumors and management](https://reader035.vdocuments.mx/reader035/viewer/2022062823/5873c73e1a28abbc788b7da5/html5/thumbnails/24.jpg)
• Therapeutic goals of Pituitary adenomas Pituitary Adenomas• Eliminate mass effect and reverse related signs
and symptoms• Normalize hormone hyper secretion and reverse
secondary effects• Preserve or recover normal pituitary function• Prevent recurrence• Increase survival• Improve quality of life
![Page 25: Pitutary tumors and management](https://reader035.vdocuments.mx/reader035/viewer/2022062823/5873c73e1a28abbc788b7da5/html5/thumbnails/25.jpg)
Management
• Medical• Surgical• Radiotherapy
![Page 26: Pitutary tumors and management](https://reader035.vdocuments.mx/reader035/viewer/2022062823/5873c73e1a28abbc788b7da5/html5/thumbnails/26.jpg)
Medical Prolactinomas : • Dopamine agonists : Bromocriptine and
cabergoline. 80-90% . GH adenomas:• Somatostatin analogs : octreotide, lanreotide.• Dopamine agonists: less effective.• GH receptor antagonist: pegvisomant : daily inj. Cushing disease: • ACTH synthesis/release: cyproheptadine,
bromocriptine, somatostatin, and valproic acid.
![Page 27: Pitutary tumors and management](https://reader035.vdocuments.mx/reader035/viewer/2022062823/5873c73e1a28abbc788b7da5/html5/thumbnails/27.jpg)
• Steroid Synthesis Inhibitor: Ketoconazole, mitotane, trilostane, aminoglutethimide and metyrapone.
![Page 28: Pitutary tumors and management](https://reader035.vdocuments.mx/reader035/viewer/2022062823/5873c73e1a28abbc788b7da5/html5/thumbnails/28.jpg)
Surgery
Indications: • Rapidly progressive vision loss.• Increase in adenoma size despite dopamine
agonists.• Intolerance or inadequate hormonal response
to medical therapy. All symptomatic Pituitary adenomas TOC is Resection Transsphenoidal Transcranial
![Page 29: Pitutary tumors and management](https://reader035.vdocuments.mx/reader035/viewer/2022062823/5873c73e1a28abbc788b7da5/html5/thumbnails/29.jpg)
Advantages : • Hormone levels normalize in 1-12 weeks.• Mass effects can be decompressed quickly • Endocrine hypersecretion decreased or
eliminated• Existing pituitary function retained or improved
rapidly Disadvantages: • Recurrence rate is relatively high with surgery
alone. B/L adrenalectomy: life long glucocorticoids.
![Page 30: Pitutary tumors and management](https://reader035.vdocuments.mx/reader035/viewer/2022062823/5873c73e1a28abbc788b7da5/html5/thumbnails/30.jpg)
Surgical Cure Rate
• Prolactinomas microadenomas-50-60% macroadenomas-25%.• GH adenomas : microadenoams- 68%• macroadenomas-54% • Cushing syndrome : 57-90%.
![Page 31: Pitutary tumors and management](https://reader035.vdocuments.mx/reader035/viewer/2022062823/5873c73e1a28abbc788b7da5/html5/thumbnails/31.jpg)
Radiation Therapy Indications : • Residual surgical tumors• Medically inoperable tumors.• Effective for controlling pitutary adenoma
growth & progression. BUT less effective in normalizing hormonal activity. 10 RT: Medically Inoperable. refusal to surgery.
![Page 32: Pitutary tumors and management](https://reader035.vdocuments.mx/reader035/viewer/2022062823/5873c73e1a28abbc788b7da5/html5/thumbnails/32.jpg)
Radiation Techniques
• Conventional Radiotherapy.• 3D-CRT• IMRT• Radiosurgery Gamma knife. Cyber knife.• Proton Therapy.
![Page 33: Pitutary tumors and management](https://reader035.vdocuments.mx/reader035/viewer/2022062823/5873c73e1a28abbc788b7da5/html5/thumbnails/33.jpg)
Conventional • Position - supine • Head and neck flexed• Head typically held at 450 .• All patients were treated in a supine position
with flexion of the head so that base of the skull was in right angle to the couch and parallel to the central plane
![Page 34: Pitutary tumors and management](https://reader035.vdocuments.mx/reader035/viewer/2022062823/5873c73e1a28abbc788b7da5/html5/thumbnails/34.jpg)
3D CRT
• CECT scan should be obtained.• When possible, CE MRI should be registered
to the planning CT scan.• Normal structures to be contoured including
the eyes (lenses), optic nerves, optic chiasm, brainstem, and temporal lobes.
![Page 35: Pitutary tumors and management](https://reader035.vdocuments.mx/reader035/viewer/2022062823/5873c73e1a28abbc788b7da5/html5/thumbnails/35.jpg)
![Page 36: Pitutary tumors and management](https://reader035.vdocuments.mx/reader035/viewer/2022062823/5873c73e1a28abbc788b7da5/html5/thumbnails/36.jpg)
Target volumes• GTV : pituitary adenoma, including any extension
into adjacent anatomic regions. • CTV: limited to a 5-mm margin around the tumor is
adequate. With invasive tumors, Often, the entire
contents of the sella and, if appropriate, the entire cavernous sinus are included in the CTV.
• PTV : Standard thermoplastic masks are associated with setup variability of the order of 3 to 4 mm.
A total PTV margin of 5 mm is usually reasonable.
![Page 37: Pitutary tumors and management](https://reader035.vdocuments.mx/reader035/viewer/2022062823/5873c73e1a28abbc788b7da5/html5/thumbnails/37.jpg)
![Page 38: Pitutary tumors and management](https://reader035.vdocuments.mx/reader035/viewer/2022062823/5873c73e1a28abbc788b7da5/html5/thumbnails/38.jpg)
• Typically 5x5 cm field used, centered on sella
![Page 39: Pitutary tumors and management](https://reader035.vdocuments.mx/reader035/viewer/2022062823/5873c73e1a28abbc788b7da5/html5/thumbnails/39.jpg)
XRT Dose Bio. control 1.8Gy/#
Nonfunctioning 45-50.4 Gy 95% NA
Functioning 50- 54 Gy 90-95% 33-95%
![Page 40: Pitutary tumors and management](https://reader035.vdocuments.mx/reader035/viewer/2022062823/5873c73e1a28abbc788b7da5/html5/thumbnails/40.jpg)
Correlation of vision improvement, tumour control with dose of radiation
therapy in 121 patients treated with surgery and XRT Dose (Gy) <30 30-39.99 40-49.99 50-54 >54 p value
% with improved visual status 14 29 42 70 0 0.003
% failure 71 25 15 6 0 <0.01
Gringsby et al. Int J Radiat Oncol Biol Phys 1989 ;16:1411
![Page 41: Pitutary tumors and management](https://reader035.vdocuments.mx/reader035/viewer/2022062823/5873c73e1a28abbc788b7da5/html5/thumbnails/41.jpg)
SRS• Dose : 10-27 Gy• Cranial hard fixation tech• Adverse CNS event : 38%• ? Higher response rate.
FSRT• Conventional doses: 45-50 Gy• Using re-locatable head frame tech• Adverse CNS event : 0%
![Page 42: Pitutary tumors and management](https://reader035.vdocuments.mx/reader035/viewer/2022062823/5873c73e1a28abbc788b7da5/html5/thumbnails/42.jpg)
• Advantages
– Rapid dose fall off outside the target volume– Conformality of prescribed dose to the target volume– Radiosurgery may provide a more rapid radiographic
and hormonal response than fractionated radiation therapy
• Different machines use– Gamma Knife– LINAC-based systems (X-Knife)– Cyber Knife
![Page 43: Pitutary tumors and management](https://reader035.vdocuments.mx/reader035/viewer/2022062823/5873c73e1a28abbc788b7da5/html5/thumbnails/43.jpg)
Patient selection criteria
• Radio logically distinct adenoma ≤ 3 cm (SRS) or Larger lesions (SRT)
• Contraindications of SRS– Lesions involved optic apparatus
– Size > 3 cm
![Page 44: Pitutary tumors and management](https://reader035.vdocuments.mx/reader035/viewer/2022062823/5873c73e1a28abbc788b7da5/html5/thumbnails/44.jpg)
Proton Therapy • Rate of energy loss – Proportional to the square of particle
charge and inversely proportional to square of its velocity
– As particle slows down rate of energy loss increases i.e. absorbed dose increase
– Bragg peak –
– The ability to concentrate dose inside the target volume and minimize dose to surrounding normal tissue
![Page 45: Pitutary tumors and management](https://reader035.vdocuments.mx/reader035/viewer/2022062823/5873c73e1a28abbc788b7da5/html5/thumbnails/45.jpg)
• Energy -either 155 or 200 MeV depending on the required beam penetration.
• PTV - all gross visible tumor (or all intrasellar contents with micro adenomas) with a 5-mm margin.
• The most common arrangement included 4 fields.
Disadvantages: • High cost of installation• Limited utility in other malignancy
![Page 46: Pitutary tumors and management](https://reader035.vdocuments.mx/reader035/viewer/2022062823/5873c73e1a28abbc788b7da5/html5/thumbnails/46.jpg)
Late effects • Late optic neuritis [0.7- 2%]• 2nd Malignant neoplasms. Royan Marsden 1.3% at 10yrs. Hospital with
1.9% at 20yrs. 45Gy. • Radiation Necrosis .• Hypopituitarism [10-30%] Surgery alone carries lower risk than RT Radiotherapy alone has lower risk than when RT
and surgery combined
![Page 47: Pitutary tumors and management](https://reader035.vdocuments.mx/reader035/viewer/2022062823/5873c73e1a28abbc788b7da5/html5/thumbnails/47.jpg)
Criteria for cure
• Tumor type Criteria Acromegaly Normalization of IGF-1 levels Random GH<2.5 ng/ml
GH<1 ng/ml (OGTT)
• PRL PRL< 20 ng/ml
• Cushing’s disease Normal 24 hour UFC
![Page 48: Pitutary tumors and management](https://reader035.vdocuments.mx/reader035/viewer/2022062823/5873c73e1a28abbc788b7da5/html5/thumbnails/48.jpg)
![Page 49: Pitutary tumors and management](https://reader035.vdocuments.mx/reader035/viewer/2022062823/5873c73e1a28abbc788b7da5/html5/thumbnails/49.jpg)
![Page 50: Pitutary tumors and management](https://reader035.vdocuments.mx/reader035/viewer/2022062823/5873c73e1a28abbc788b7da5/html5/thumbnails/50.jpg)
![Page 51: Pitutary tumors and management](https://reader035.vdocuments.mx/reader035/viewer/2022062823/5873c73e1a28abbc788b7da5/html5/thumbnails/51.jpg)
Conclusion • Small organ but critical functions for normal
development, growth, organ regulation, reproductive regulation, birthing functions.
• Dysfunction – endocrine abnormalities & mass effects.
• Chronic hypopituitarism – mortality due to cardiovascular events.
• Cumulative role of medical management & radiotherapy.
• No change in the quality of life when hormone deficiencies are suitably replaced.
![Page 52: Pitutary tumors and management](https://reader035.vdocuments.mx/reader035/viewer/2022062823/5873c73e1a28abbc788b7da5/html5/thumbnails/52.jpg)
Thank you